#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Iceland

  • Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

    Recruiting

    1 1 1
    Investigated drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Study on the Safety and Effects of NPI-001 (Acetylcysteine Amide) for Patients Aged 50-85 with Mild Cognitive Impairment or Mild Alzheimer’s Disease

    Recruiting

    1
    Investigated drugs:
    • Acetylcysteine Amide
    Denmark Iceland

  • Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

    Recruiting

    1 1 1
    Investigated diseases:
    • Follicular lymphoma
    Investigated drugs:
    • Lenalidomide
    • Rituximab
    • Tafasitamab
    Denmark Finland Iceland Norway Sweden

  • Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Dalteparin Sodium
    • Enoxaparin Sodium
    • Nadroparin Calcium
    Denmark Finland Iceland The Netherlands Sweden

  • Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Bladder transitional cell carcinoma
    Investigated drugs:
    • Mitomycin
    • Bcg (Bacillus Calmette-Guérin) Bacteria
    Denmark Iceland Norway Sweden

  • Study on the Safety and Effectiveness of Terbinafine Solution for Treating Mild to Moderate Nail Fungus in Children Aged 6-17 Years

    Recruiting

    1 1 1
    Investigated drugs:
    • Terbinafine
    • Terbinafine Hydrochloride
    Denmark Iceland Italy Poland
1 2 3 … 5
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Acetylcysteine Amide Bcg (Bacillus Calmette-Guérin) Bacteria Prednisolone Sodium Succinate Aficamten Cytarabine Dexamethasone Lenalidomide Pelacarsen Methotrexate Etoposide Nadroparin Calcium Inotuzumab Ozogamicin Olaparib 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One Fludarabine Phosphate Tinzaparin Sodium Mercaptopurine Abatacept Secukinumab Docetaxel Gemtuzumab Ozogamicin Human Plasma Proteins With Not Less Than 96% Albumin Methylprednisolone Sodium Succinate Triamcinolone Hexacetonide Prednisone Terbinafine Hydrocortisone Rituximab Hydroxychloroquine Sulfate Apixaban Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute lymphocytic leukaemia Acute myeloid leukaemia Arteriosclerosis Atrial fibrillation Bladder transitional cell carcinoma Breast cancer Cerebral amyloid angiopathy Chronic kidney disease Coronary artery disease Dyslipidaemia Dyspepsia End stage renal disease Follicular lymphoma Hypertrophic cardiomyopathy Infertility Intensive care Non-small cell lung cancer Plasma cell myeloma Primary biliary cholangitis Rheumatoid arthritis Small cell lung cancer extensive stage Transitional cell carcinoma

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!